MIRA Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MIRA and other ETFs, options, and stocks.

About MIRA

MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. It engages in developing its product candidates, Ketamir-2 and MIRA-55, designed to address unmet medical needs in pain management, depression, PTSD, and cognitive function. 

CEO
Erez Aminov
CEOErez Aminov
Employees
5
Employees5
Headquarters
Miami, Florida
HeadquartersMiami, Florida
Founded
2020
Founded2020
Employees
5
Employees5

MIRA Key Statistics

Market cap
63.02M
Market cap63.02M
Price-Earnings ratio
-0.97
Price-Earnings ratio-0.97
Dividend yield
Dividend yield
Average volume
224.37K
Average volume224.37K
High today
$1.48
High today$1.48
Low today
$1.48
Low today$1.48
Open price
$1.45
Open price$1.45
Volume
1.80K
Volume1.80K
52 Week high
$2.45
52 Week high$2.45
52 Week low
$0.73
52 Week low$0.73

Stock Snapshot

With a market cap of 63.02M, MIRA Pharmaceuticals(MIRA) trades at $1.48. The stock has a price-to-earnings ratio of -0.97.

During the trading session on 2025-12-18, MIRA Pharmaceuticals(MIRA) shares reached a daily high of $1.48 and a low of $1.48. At a current price of $1.48, the stock is 0.0% higher than the low and still 0.0% under the high.

Trading volume for MIRA Pharmaceuticals(MIRA) stock has reached 1.8K, versus its average volume of 224.37K.

Over the past 52 weeks, MIRA Pharmaceuticals(MIRA) stock has traded between a high of $2.45 and a low of $0.73.

Over the past 52 weeks, MIRA Pharmaceuticals(MIRA) stock has traded between a high of $2.45 and a low of $0.73.

People also own

Based on the portfolios of people who own MIRA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.